Tango Bypasses IPO Route With SPAC Merger
Cancer Firm Will Raise $353m, List On US Stock Market In Q3
The cancer drug developer was planning to go public later this year, but its series B investor Boxer Capital proposed a merger with its special purpose acquisition corporation, BCTG Acquisition.
